Ulcerative colitis and microsatellite instability
Ulcerative colitis and microsatellite instability
Disciplines
Biology (15%); Clinical Medicine (10%); Medical-Theoretical Sciences, Pharmacy (75%)
Keywords
-
Ulcerative Colitis,
Chemoprevention,
Microsatellite Instability,
Mesalazine,
Inflammation,
Neutrophils
Chronic inflammation in ulcerative colitis leads to the development of colorectal cancer. The inflammatory infiltrate creates a hypermutable environment that initiates and drives neoplastic progression. Neutrophils are the predominant cells in this setting, which may penetrate the mucosal barrier and form crypt abscesses. Our lab recently demonstrated that such activated neutrophils lead to replication errors and cause mutations at microsatellites. Such microsatellite instability can be detected in chronically inflamed mucosa and seems to be an early event in the development of colitis-associated cancer. For this project we aim to dissect the culprit factor(s) responsible for microsatellite instability using a coculture system with primary human colonic epithelial cells and certain colitis mouse models that develop microsatellite mutations and cancer. Antagonists will also be tested both in vitro and in vivo.
Ulcerative colitis is characterized by chronic intestinal inflammation with increased risk for the development of colorectal cancer. The inflammatory infiltrate creates an environment in the intestine, which leads to mutations in repetitive DNA sequences, so called microsatellites, in the intestinal mucosa. Microsatellite instability can already be detected in chronic inflamed mucosa (before the onset of cancer) and is considered a key factor for the development of colitis-associated colorectal cancer. Within this project we identified signaling molecules, released by certain immune cells, which lead to mutations in intestinal epithelial cells. Inhibition of these signaling peptides and reactive oxygen species reduced mutations in a culture system of intestinal epithelial cells and granulocytes. To verify our promising results in a mouse model, we created IL-10xMSH2 double knockout (DKO) mice, with a defective mismatch repair system and prone to develop colitis. According to our hypothesis, these IL-10xMSH2 DKO mice developed more colonic tumors compared to single KO mice. Tumors presented mostly right-sided and bacteria were colonizing tumor crypts, an observation characteristic for IL-10 and DKO mice. Using this mouse model we studied the inhibition of signaling molecules for the prevention of colorectal cancer, unfortunately with negative result. The identification of tumor-colonizing bacteria, however, opens the opportunity to study the relationship between intestinal microbiota and colon cancer.
- Winfried Edelmann, Albert Einstein College of Medicine - USA
- Terrence A. Barrett, University of Kentucky Medical Center - USA
- Jerry W. Shay, University of Texas Southwestern Medical Center - USA
Research Output
- 457 Citations
- 14 Publications
-
2015
Title Increased expression of HIF2a during iron deficiency–associated megakaryocytic differentiation DOI 10.1111/jth.12884 Type Journal Article Author Jimenez K Journal Journal of Thrombosis and Haemostasis Pages 1113-1127 Link Publication -
2014
Title Tracing PAKs from GI inflammation to cancer DOI 10.1136/gutjnl-2014-306768 Type Journal Article Author Dammann K Journal Gut Pages 1173 Link Publication -
2015
Title PAK1 modulates a PPAR?/NF-?B cascade in intestinal inflammation DOI 10.1016/j.bbamcr.2015.05.031 Type Journal Article Author Dammann K Journal Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Pages 2349-2360 Link Publication -
2015
Title Overexpression of PAK1 Promotes Cell Survival in Inflammatory Bowel Diseases and Colitis-associated Cancer DOI 10.1097/mib.0000000000000281 Type Journal Article Author Khare V Journal Inflammatory Bowel Diseases Pages 287-296 Link Publication -
2015
Title Positive Effekte von NSAR auf den Gastrointestinaltrakt. Type Journal Article Author Gasche C Et Al -
2017
Title Identification of PMN-released mutagenic factors in a co-culture model for colitis-associated cancer DOI 10.1093/carcin/bgx118 Type Journal Article Author Granofszky N Journal Carcinogenesis Pages 146-157 Link Publication -
2017
Title HuR Small-Molecule Inhibitor Elicits Differential Effects in Adenomatosis Polyposis and Colorectal Carcinogenesis DOI 10.1158/0008-5472.can-15-1726 Type Journal Article Author Lang M Journal Cancer Research Pages 2424-2438 Link Publication -
2012
Title MSH3-Deficiency Initiates EMAST without Oncogenic Transformation of Human Colon Epithelial Cells DOI 10.1371/journal.pone.0050541 Type Journal Article Author Campregher C Journal PLoS ONE Link Publication -
2014
Title Chemoprevention of Colorectal Cancer DOI 10.1159/000366037 Type Journal Article Author Lang M Journal Digestive Diseases Pages 58-67 Link Publication -
2014
Title Republished: Tracing PAKs from GI inflammation to cancer DOI 10.1136/postgradmedj-2014-306768rep Type Journal Article Author Dammann K Journal Postgraduate Medical Journal Pages 657-668 Link Publication -
2013
Title Kolorektales Karzinom: Screening und Surveillance bei chronisch entzündlichen Darmerkrankungen - Konsensus der Arbeitsgruppe für chronisch entzündliche Darmerkrankungen der ÖGGH DOI 10.1055/s-0033-1335252 Type Journal Article Author Angelberger S Journal Zeitschrift für Gastroenterologie Pages 450-457 -
2014
Title Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2loxP/loxP Villin-Cre mice DOI 10.1136/gutjnl-2014-307663 Type Journal Article Author Kortüm B Journal Gut Pages 1905 Link Publication -
2013
Title Thymoquinone attenuates tumor growth in ApcMin mice by interference with Wnt-signaling DOI 10.1186/1476-4598-12-41 Type Journal Article Author Lang M Journal Molecular Cancer Pages 41 Link Publication -
2013
Title Modulation of N-glycosylation by mesalamine facilitates membranous E-cadherin expression in colon epithelial cells DOI 10.1016/j.bcp.2013.10.021 Type Journal Article Author Khare V Journal Biochemical Pharmacology Pages 312-320 Link Publication